NEORX
Poniard Pharmaceuticals, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78197762 |
| Registration Number | 2831957 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Cancellation Code | 2 |
| Attorney Name | Rochelle D. Alpert |
| Attorney Docket Number | 019425.2120 |
| Law Office Assigned | M10 |
| Employee Name | ISAACSON, VIRGINIA T |
Timeline
| 2002-01-06 | Date of First Use |
| 2002-12-24 | Application Filed |
| 2004-01-20 | Published for Opposition |
| 2004-04-13 | Trademark Registered |
| 2004-05-17 | Location: FILE REPOSITORY (FRANCONIA) |
| 2010-11-19 | Cancelled |
| 2010-11-19 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  PONIARD PHARMACEUTICALS, INC. |
| Address | 300 ELLIOTT AVENUE WEST, SUITE 500 SEATTLE WA 98119 |
| Legal Entity Type | Corporation |
| Legal Entity State | WA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 241717 | Prescription symbol (Rx) |
| 261312 | Quadrilaterals with bars, bands and lines |
| 261321 | Quadrilaterals that are completely or partially shaded |
Attorney of Record
Good, Services, and Codes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 40 |
| U.S. Codes: | 100,103,106 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | Diagnostic pharmaceutical products and reagents, namely biochemical and biological reagents for localizing active agents for use in pharmaceutical and scientific research |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2003-05-06 | 1 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2003-05-08 | 2 TCCA I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2003-06-02 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION E-MAILED | 2003-06-05 | 4 GNRT F:First Action |
| PAPER RECEIVED | 2003-08-01 | 5 MAIL I:Incoming Correspondence |
| CASE FILE IN TICRS | 2003-08-29 | 6 CFIT O:Outgoing Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2003-08-01 | 7 CRFA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2003-09-15 | 8 CNSA O:Outgoing Correspondence |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2003-11-14 | 9 ZZZX Z:Deletion |
| EXAMINERS AMENDMENT E-MAILED | 2003-11-21 | 10 GNEA O:Outgoing Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2003-11-24 | 11 CNSA O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2003-12-31 | 12 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2004-01-20 | 13 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2004-04-13 | 14 R.PR A:Allowance for Publication |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2006-06-21 | 15 ASGN I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2010-11-19 | 16 C8.. O:Outgoing Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 